Creatine and Creatinine Metabolism - Physiological Reviews

More documents

Recommendations

Info

1200 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80 duces changes in the level of mRNAs coding for stress protein 71 and creatine kinase M. Circ Res 63: 512–517, 1988. 631. MEKHFI H, HOERTER J, LAUER C, WISNEWSKY C, SCHWARTZ K, AND VENTURA-CLAPIER R. Myocardial adaptation to creatine deficiency in rats fed with �-guanidinopropionic acid, a creatine analogue. Am J Physiol Heart Circ Physiol 258: H1151–H1158, 1990. 632. MEKHFI H, VEKSLER V, MATEO P, MAUPOIL V, ROCHETTE L, AND VENTURA-CLAPIER R. Creatine kinase is the main target of reactive oxygen species in cardiac myofibrils. Circ Res 78: 1016– 1027, 1996. 633. MESKYS R, RUDOMANSKIS R, AND LEIPUVIENE R. Cloning of genes encoding heterotetrameric sarcosine oxidase from Arthrobacter sp. Biotechnol Lett 18: 781–786, 1996. 634. METHFESSEL J. Transamidinase. Zschr Inn Med 25: 80–84, 1970. 635. MEYER MH, SMITH S, AND MEYER RA. Creatinine assay by the Fuller’s earth procedure or by enzymatic determination is adequate for urine but not plasma of mice. Comp Biochem Physiol B Biochem 106: 685–689, 1993. 636. MEYER RA. Linear dependence of muscle phosphocreatine kinetics on total creatine content. Am J Physiol Cell Physiol 257: C1149–C1157, 1989. 637. MEYER RA, BROWN TR, KRILOWICZ BL, AND KUSHMERICK MJ. Phosphagen and intracellular pH changes during contraction of creatine-depleted rat muscle. Am J Physiol Cell Physiol 250: C264–C274, 1986. 638. MIKAMI H, ORITA Y, ANDO A, FUJII M, KIKUCHI T, YOSHIHARA K, OKADA A, AND ABE H. Metabolic pathway of guanidino compounds in chronic renal failure. In: Urea Cycle Diseases, edited by A. Lowenthal, A. Mori, and B. Marescau. New York: Plenum, 1982, p. 449–458. 639. MILHORAT AT. Creatine and creatinine metabolism and diseases of the neuro-muscular system. In: Metabolic and Toxic Diseases of the Nervous System, edited by H. H. Merritt and C. C. Hare. Baltimore, MD: Williams & Wilkins, 1953, p. 400–421. 640. MILLANVOYE-VAN BRUSSEL E, FREYSS-BEGUIN M, GRIFFA- TON G, AND LECHAT P. Energy metabolism of cardiac cell cultures during oxygen deprivation: effects of creatine and arachidonic acid. Biochem Pharmacol 34: 145–147, 1985. 641. MILLER EE, EVANS AE, AND COHN M. Inhibition of rate of tumor growth by creatine and cyclocreatine. Proc Natl Acad Sci USA 90: 3304–3308, 1993. 642. MILLER K, HALOW J, AND KORETSKY AP. Phosphocreatine protects transgenic mouse liver expressing creatine kinase from hypoxia and ischemia. Am J Physiol Cell Physiol 265: C1544–C1551, 1993. 643. MILLER K, SHARER K, SUHAN J, AND KORETSKY AP. Expression of functional mitochondrial creatine kinase in liver of transgenic mice. Am J Physiol Cell Physiol 272: C1193–C1202, 1997. 644. MIN K-L, STEGHENS J-P, HENRY R, DOUTHEAU A, AND COL- LOMBEL C. Identification of the creatine binding domain of creatine kinase by photoaffinity labeling. Biochim Biophys Acta 1387: 80–88, 1998. 645. MIN K-L, STEGHENS J-P, HENRY R, DOUTHEAU A, AND COL- LOMBEL C. Synthesis and differential properties of creatine analogues as inhibitors for human creatine kinase isoenzymes. Eur J Biochem 238: 446–452, 1996. 646. MINAJEVA A, VENTURA-CLAPIER R, AND VEKSLER V. Ca 2� uptake by cardiac sarcoplasmic reticulum ATPase in situ strongly depends on bound creatine kinase. Pflügers Arch 432: 904–912, 1996. 647. MINDERHOUD JM, MOOYAART EL, KAMMAN RL, TEELKEN AW, HOOGSTRATEN MC, VENCKEN LM, GRAVENMADE EJ, AND VAN DEN BURG W. In vivo phosphorus magnetic resonance spectroscopy in multiple sclerosis. Arch Neurol 49: 161–165, 1992. 648. MINKOFF L, GAERTNER G, DARAB M, MERCIER C, AND LEVIN ML. Inhibition of brain sodium-potassium ATPase in uremic rats. J Lab Clin Invest 80: 71–78, 1972. 649. MIRVISH SS. The etiology of gastric cancer. Intragastric nitrosamide formation and other theories. J Natl Cancer Inst 71: 629– 647, 1983. 650. MIRVISH SS, CAIRNES DA, HERMES NH, AND RAHA CR. Creat- inine: a food component that is nitrosated-denitrosated to yield methylurea. J Agric Food Chem 30: 824–828, 1982. 651. MIRVISH SS, DESHPANDE A, HAIGHT R, NICKOLS J, MCWIL- LIAMS N, BABCOOK DM, AND MORRIS CR. Creatinine nitrosation to yield 5-oxocreatinine 5-oxime and 1-methyl-5-oxohydantoin 5-oxime: reaction rates, identification of syn and anti oxime isomers, and their interconversion by nitrite. J Agric Food Chem 41: 2051–2055, 1993. 652. MITCH WE, COLLIER VU, AND WALSER M. Creatinine metabolism in chronic renal failure. Clin Sci 58: 327–335, 1980. 653. MIURA T, MURAOKA S, AND OGISO T. Adriamycin-Fe 3� -induced inactivation of rat heart mitochondrial creatine kinase: sensitivity to lipid peroxidation. Biol Pharm Bull 17: 1220–1223, 1994. 654. MIYOSHI K, TAIRA A, YOSHIDA K, TAMURA K, AND UGA S. Abnormalities of creatinase in skeletal muscle of patients with Duchenne muscular dystrophy. Proc Jpn Acad 56: 99–101, 1980. 655. MIYOSHI K, TAIRA A, YOSHIDA K, TAMURA K, AND UGA S. Presence of creatinase and sarcosine dehydrogenase in human skeletal muscle. Proposal for creatine-urea pathway. Proc Jpn Acad 56: 95–98, 1980. 656. MOERLAND TS AND KUSHMERICK MJ. Contractile economy and aerobic recovery metabolism in skeletal muscle adapted to creatine depletion. Am J Physiol Cell Physiol 267: C127–C137, 1994. 657. MOERLAND TS, WOLF NG, AND KUSHMERICK MJ. Administration of a creatine analog induces isomyosin transitions in muscle. Am J Physiol Cell Physiol 257: C810–C816, 1989. 658. MOKHTAR N, ROUSSEAU-MIGNERON S, TANCRÈDE G, AND NADEAU A. Physical training attenuates phosphocreatine and long-chain acyl-CoA alterations in diabetic rat heart. J Appl Physiol 74: 1785–1790, 1993. 659. MÖLLER A AND HAMPRECHT B. Creatine transport in cultured cells of rat and mouse brain. J Neurochem 52: 544–550, 1989. 660. MÖLLER B, HIPPE H, AND GOTTSCHALK G. Degradation of various amine compounds by mesophilic clostridia. Arch Microbiol 145: 85–90, 1986. 661. MONTAGNA P. Magnetic resonance spectroscopy in migraine. Cephalalgia 15: 323–327, 1995. 662. MONTAGNA P, LODI R, CORTELLI P, PIERANGELI G, IOTTI S, CEVOLI S, ZANIOL P, AND BARBIROLI B. Phosphorus magnetic resonance spectroscopy in cluster headache. Neurology 48: 113– 118, 1997. 663. MONTAGNA P, MARTINELLI P, CORTELLI P, ZANIOL P, LUGA- RESI E, AND BARBIROLI B. Brain 31 P-magnetic resonance spectroscopy in mitochondrial cytopathies. Ann Neurol 31: 451–452, 1992. 664. MOORE NP, GRAY TJB, AND TIMBRELL JA. Creatine metabolism in the seminiferous epithelium of rats. I. Creatine synthesis by isolated and cultured cells. J Reprod Fertil 112: 325–330, 1998. 665. MOORE NP, GRAY TJB, AND TIMBRELL JA. Creatine metabolism in the seminiferous epithelium of rats. II. Effect of modulators of cellular biochemical function on creatine secretion by cultured Sertoli cells. J Reprod Fertil 112: 331–336, 1998. 666. MOOS C AND FENG I-NM. Pyrophosphate contamination in crystalline phosphocreatine: a source of error in kinetic studies using coupled enzymes. Anal Biochem 87: 272–277, 1978. 667. MORGELLO S, WOLFE D, GODFREY E, FEINSTEIN R, TAGLIATI M, AND SIMPSON DM. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy. Acta Neuropathol 90: 366–374, 1995. 668. MORRISON JF. Arginine kinase and other invertebrate guanidino kinases. In: The Enzymes (3rd ed.), edited by P. D. Boyer. New York: Academic, 1973, p. 457–486. 669. MORRISON JF AND ENNOR AH. N-phosphorylated guanidines. In: The Enzymes (2nd ed.), edited by P. D. Boyer, H. Lardy, and K. Myrbäck. New York: Academic, 1960, p. 89–109. 670. MORRISON LD, ELING TE, AND JOSEPHY PD. Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3-methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ. Mutat Res 302: 45–52, 1993. 671. MUDD SH, EBERT MH, AND SCRIVER CR. Labile methyl group balances in the human: the role of sarcosine. Metabolism 29: 707–720, 1980. 672. MÜHLEBACH SM, GROSS M, WIRZ T, WALLIMANN T, PERRI-
July 2000 CREATINE AND CREATININE METABOLISM 1201 ARD J-C, AND WYSS M. Sequence homology and structure predictions of the creatine kinase isoenzymes. Mol Cell Biochem 133: 245–262, 1994. 673. MUJIKA I, CHATARD J-C, LACOSTE L, BARALE F, AND GEYS- SANT A. Creatine supplementation does not improve sprint performance in competitive swimmers. Med Sci Sports Exercise 28: 1435–1441, 1996. 674. MUJIKA I AND PADILLA S. Creatine supplementation as an ergogenic aid for sports performance in highly trained athletes: a critical review. Int J Sports Med 18: 491–496, 1997. 675. MUKHERJEE A, WONG TM, TEMPLETON G, BUJA LM, AND WILLERSON JT. Influence of volume dilution, lactate, phosphate, and calcium on mitochondrial functions. Am J Physiol Heart Circ Physiol 237: H224–H238, 1979. 676. MULVANEY PT, STRACKE ML, NAM SW, WOODHOUSE E, O’KEEFE M, CLAIR T, LIOTTA LA, KHADDURAH-DAOUK R, AND SCHIFFMANN E. Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase. Int J Cancer 78: 46–52, 1998. 677. MURAKAMI F, KITAURA M, TSUJI T, KOSOGABE Y, KABUTAN K, ITOH T, INOUE M, AND HIRAKAWA M. The effects of stylene maleimide-superoxide dismutase (SMA-SOD) on guanidine compounds in rats with ischaemic acute renal failure. In: Guanidino Compounds in Biology and Medicine, edited by P. P. De Deyn, B. Marescau, V. Stalon, and I. A. Qureshi. London: Libbey, 1992, p. 327–328. 678. MURAKAMI Y, ZHANG J, EIJGELSHOVEN MHJ, CHEN W, CAR- LYLE WC, ZHANG Y, GONG G, AND BACHE RJ. Myocardial creatine kinase kinetics in hearts with postinfarction left ventricular remodeling. Am J Physiol Heart Circ Physiol 276: H892–H900, 1999. 679. MURPHY MP, PACKER MA, SCARLETT JL, AND MARTIN SW. Peroxynitrite: a biologically significant oxidant. Gen Pharmacol 31: 179–186, 1998. 680. MURRAY M AND HOFFMANN CR. The occurrence of guanidinelike substances in the blood in essential epilepsy. J Lab Clin Med 25: 1072–1073, 1940. 681. MURZIN AG. Can homologous proteins evolve different enzymatic activities? Trends Biochem Sci 18: 403–405, 1993. 682. NAGAO M, USHIJIMA T, TOYOTA M, INOUE R, AND SUGIMURA T. Genetic changes induced by heterocyclic amines. Mutat Res 376: 161–167, 1997. 683. NAGASE S, AOYAGI K, HIRAYAMA A, GOTOH M, UEDA A, TOMIDA C, KIKUCHI H, TAKEMURA K, AND KOYAMA A. Decreased serum antioxidant activity of hemodialysis patients demonstrated by methylguanidine synthesis and microsomal lipid peroxidation. Nephron 74: 555–560, 1996. 684. NAGASE S, AOYAGI K, NARITA M, AND TOJO S. Biosynthesis of methylguanidine in isolated rat hepatocytes and in vivo. Nephron 40: 470–475, 1985. 685. NAKAJIMA M, SHIROKANE Y, AND MIZUSAWA K. A new amidinohydrolase, methylguanidine amidinohydrolase from Alcaligenes sp. N-42. FEBS Lett 110: 43–46, 1980. 686. NAKAMURA K AND IENAGA K. Creatol (5-hydroxycreatinine), a new toxin candidate in uremic patients. Experientia 46: 470–472, 1990. 687. NAKAMURA K, IENAGA K, NAKANO K, NAKAI M, NAKAMURA Y, HASEGAWA G, SAWADA M, KONDO M, MORI H, AND KANAT- SUNA T. Diabetic renal failure and serum accumulation of the creatinine oxidative metabolites creatol and methylguanidine. Nephron 73: 520–525, 1996. 688. NAKAMURA K, IENAGA K, YOKOZAWA T, FUJITSUKA N, AND OURA H. Production of methylguanidine from creatinine via creatol by active oxygen species: analyses of the catabolism in vitro. Nephron 58: 42–46, 1991. 689. NASCIMBEN L, FRIEDRICH J, LIAO R, PAULETTO P, PESSINA AC, AND INGWALL JS. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation 91: 1824–1833, 1995. 690. NASCIMBEN L, INGWALL JS, PAULETTO P, FRIEDRICH J, GWATHMEY JK, SAKS V, PESSINA AC, AND ALLEN PD. Creatine kinase system in failing and nonfailing human myocardium. Circulation 94: 1894–1901, 1996. 691. NASH SR, GIROS B, KINGSMORE SF, ROCHELLE JM, SUTER ST, GREGOR P, SELDIN MF, AND CARON MG. Cloning, pharmacological characterization, and genomic localization of the human creatine transporter. Receptors Channels 2: 165–174, 1994. 692. NATELSON S. Metabolic relationship between urea and guanidino compounds as studied by automated fluorimetry of guanidino compounds in urine. Clin Chem 30: 252–258, 1984. 693. NAVON G, GOGOL E, AND WEISSENBERG R. Phosphorus-31 and proton NMR analysis of reproductive organs of male rats. Arch Androl 15: 153–157, 1985. 694. NAYLER WG, FERRARI R, AND WILLIAMS A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol 46: 242–248, 1980. 695. NEELY JR, ROVETTO MJ, WHITMER JT, AND MORGAN HE. Effects of ischemia on function and metabolism of the isolated working rat heart. Am J Physiol 225: 651–658, 1973. 696. NELSON L AND DELGADO-ESCUETA AV. Fluidity of normal and epileptogenic freeze-lesioned synaptic membranes in the cat. Brain Res 386: 32–40, 1986. 697. NELSON N. Presynaptic events involved in neurotransmission. J Physiol (Paris) 87: 171–178, 1993. 698. NEUBAUER S, FRANK M, HU K, REMKES H, LASER A, HORN M, ERTL G, AND LOHSE MJ. Changes of creatine kinase gene expression in rat heart post-myocardial infarction. J Mol Cell Cardiol 30: 803–810, 1998. 699. NEUBAUER S, HAMMAN BL, PERRY SB, BITTL JA, AND ING- WALL JS. Velocity of the creatine kinase reaction decreases in postischemic myocardium: a 31 P-NMR magnetization transfer study of the isolated ferret heart. Circ Res 63: 1–15, 1988. 700. NEUBAUER S, HORN M, HAHN D, AND KOCHSIEK K. Clinical cardiac magnetic resonance spectroscopy: present state and future directions. Mol Cell Biochem 184: 439–443, 1998. 701. NEUBAUER S AND INGWALL JS. Verapamil attenuates ATP depletion during hypoxia: 31 P NMR studies of the isolated rat heart. J Mol Cell Cardiol 21: 1163–1178, 1989. 702. NEUROHR KJ, GOLLIN G, BARRETT EJ, AND SHULMAN RG. In vivo 31 P-NMR studies of myocardial high energy phosphate metabolism during anoxia and recovery. FEBS Lett 159: 207–210, 1983. 703. NICOLAY K, AUE WP, SEELIG J, VAN ECHTELD CJA, RUIGROK TJC, AND DE KRUIJFF B. Effects of the anti-cancer drug adriamycin on the energy metabolism of rat heart as measured by in vivo 31 P-NMR and implications for adriamycin-induced cardiotoxicity. Biochim Biophys Acta 929: 5–13, 1987. 704. NIKLASSON F AND ÅGREN H. Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood. Biol Psychiatry 19: 1183–1206, 1984. 705. NIKOLOVA-KARAKASHIAN MN, PETKOVA H, AND KOUMANOV KS. Influence of cholesterol on sphingomyelin metabolism and hemileaflet fluidity of rat liver plasma membranes. Biochimie 74: 153–159, 1992. 706. NISHIYA Y AND IMANAKA T. Analysis of interaction between the Arthrobacter sarcosine oxidase and the coenzyme flavin adenine dinucleotide by site-directed mutagenesis. Appl Environ Microbiol 62: 2405–2410, 1996. 707. NISHIYA Y, KAWAMURA Y, AND IMANAKA T. Enzymatic assay for chloride ion with chloride-dependent sarcosine oxidase created by site-directed mutagenesis. Anal Biochem 245: 127–132, 1997. 708. NISHIYA Y, TODA A, AND IMANAKA T. Gene cluster for creatinine degradation in Arthrobacter sp. TE1826. Mol Gen Genet 257: 581– 586, 1998. 709. NISHIYA Y, ZUIHARA S, AND IMANAKA T. Active site analysis and stabilization of sarcosine oxidase by the substitution of cysteine residues. Appl Environ Microbiol 61: 367–370, 1995. 710. NUKAYA H, KOYOTA S, JINNO F, ISHIDA H, WAKABAYASHI K, KUROSAKA R, KIM I-S, YAMAIZUMI Z, USHIYAMA H, SUG- IMURA T, NAGAO M, AND TSUJI K. Structural determination of a new mutagenic heterocyclic amine, 2-amino-1,7,9-trimethylimi-
Page 1 and 2:
PHYSIOLOGICAL REVIEWS Vol. 80, No.
Page 3 and 4:
July 2000 CREATINE AND CREATININE M
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44: July 2000 CREATINE AND CREATININE M
Page 93: July 2000 CREATINE AND CREATININE M
Page 107: July 2000 CREATINE AND CREATININE M
show all

Creatine and Creatinine Metabolism - Physiological Reviews

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?